CVS Group (CVSG) H1 analyst presentation given 25.3.21

Richard Fairman, CEO, Robin Alfonso, CFO and Ben Jacklin, COO present the CVSG interim results to analysts.

Richard Fairman, CEO
00:18 Introduction
01:09 H1 highlights
01:55 UK Pet Market
03:45 Integrated model
07:15 Trading with CV19
10:15 Acquisitions

Robin Alfonso, CFO
10:55 Financial review

Ben Jacklin, COO
16:30 Operational update

Richard Fairman, CEO
22:15 Outlook

Q&A 24:16

CVS Group plc is a holding company. The principal activities of the Company are to operate animal veterinary practices, veterinary diagnostic businesses, pet crematoria and an online pharmacy and retail business. Its segments are Veterinary Practice, Laboratories, Pet Crematoria and Animed Direct. The Veterinary Practice segment offers treatment for companion animals, equine and farm animals. The Laboratories segment provides diagnostic services to its veterinary practices and third-parties. Its laboratories provide Biochemistry, haematology, histology, serology and advanced allergy testing. The Pet Crematoria segment offers pet cremation services to its veterinary practices, third-party practices and directly to pet owners. The Animed Direct segment sells prescription and non-prescription drugs, pet food and other animal related products through its Website. It operates approximately 360 veterinary practices, four diagnostic laboratories, seven pet crematoria and an online dispensary.

You might be interested in